DaVita, Inc.
Company reports 2004 income of $217.2 million, $2.11 per share
Published in Healthcare Finance, Tax and Law Weekly, March 16th, 2005
Net income for the 3 months ended December 31, 2004, was $56.6 million and $0.56 per share. Net income for the year ended December 31, 2004, was $217.2 million, and $2.11 per share, excluding after-tax Medicare lab recoveries of $5.1 million.
Net income for the year ended December 31, 2004, including the lab recoveries (generally accepted accounting principles basis), was $222.3 million and $2.16 per share.
Cash flow for the 12 months ended December 31, 2004, was the company's strongest ever with operating cash flow and free cash flow of $361...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AEterna Zentaris, Inc.
AEterna Zentaris subsidiary files preliminary prospectus for IPO - AFP Imaging Corporation
Imaging company reports record profitable second quarter - Abortion
Bill would require viewing graphic photos before abortion - Accentia Biopharmaceuticals, Inc.
Biopharmaceutical company reports plans for initial public offering - Advanced Neuromodulation Systems, Inc.
Medical device firm reports 26% increase in fourth quarter revenue - Advanced Nutraceuticals, Inc.
Nutraceutical company reports income of $0.08 per share - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
